Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of RB Naproxen Sodium vs Aleve in Healthy Fasted Subjects
NCT03167541Phase 1Completed
- Sponsor
- Reckitt
- Start
- Oct 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of Aprol in pain (2 arms), sponsored by Reckitt. Primary endpoints: Area Under Plasma Concentration-time from time 0 to time t and Maximum Plasma Concentration. Started Oct 2016; status: completed.
02
Drugs
Aprol
03
Conditions
pain
Beyond the preview
Go deeper on NCT03167541.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03167541.